Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-29

FDA Approved: VOCABRIA — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

The FDA approved a supplemental application for VOCABRIA (cabotegravir sodium) from ViiV Healthcare Company, enabling changes to the drug's labeling and/or indi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VOCABRIA (cabotegravir sodium)

Snippet

SUPPL AP for VOCABRIA (CABOTEGRAVIR SODIUM)